Frovatriptan Succinate Monohydrate | CAS 158930-17-7 - 请求报价
Frovatriptan Succinate Monohydrate
| SZ目录编号: | SZ-F018001 |
| CAS 号 | 158930-17-7 |
| 分子式 | C14H17N3O : C4H6O4 : H2O |
| 分子量 | 243.3 : 118.1 : 18.0 |
| 投资状态 | Synthesis on demand |
| Rel. CAT No | SZ-F018025 |
| Rel. CAS No | 158747-02-5 (free base) ; 158747-00-3 (HCl salt) ; 158930-16-6 (HBr salt) ; 158930-09-7 (Succinate salt) |
| 运输条件 | Room Temperature |
化学名称 :
运输温度 :
HSN编码 :
原产国 :
微笑 :
使用说明:
Frovatriptan Succinate Monohydrate is chemically (R)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide succinate hydrate. Frovatriptan Succinate Monohydrate is supplied with detailed characterization data compliant with regulatory guideline. Frovatriptan Succinate Monohydrate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Frovatriptan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
应用与法规使用场景
购买 158930-17-7
采购 158930-17-7
订购 158930-17-7
询问 158930-17-7
price of 158930-17-7
158930-17-7 供应商
158930-17-7 制造商
158930-17-7 出口商
buy high quality Frovatriptan Succinate Monohydrate
采购 Frovatriptan Succinate Monohydrate
Frovatriptan Succinate Monohydrate 供应商
Frovatriptan Succinate Monohydrate 制造商
Frovatriptan Succinate Monohydrate 价格
订购 Frovatriptan Succinate Monohydrate
询问 Frovatriptan Succinate Monohydrate
Frovatriptan Succinate Monohydrate 成本
Frovatriptan Succinate Monohydrate 供应商
Frovatriptan Succinate Monohydrate 分销商
Frovatriptan Succinate Monohydrate 用于方法验证
Frovatriptan 对照标准
Frovatriptan Succinate Monohydrate 用于ANDA申报
Frovatriptan Succinate Monohydrate 用于强制降解研究
Frovatriptan Succinate Monohydrate 鉴别标准
Frovatriptan Succinate Monohydrate 用于DMF申报
相关产品
免责声明
SynZeal 在本网站上提供的产品信息是根据发布时的现有理解而提供的。客户在实际购买时有责任评估信息的准确性。
SynZeal 将根据产品规格的新发展或新发现更新这些详细信息,恕不另行通知。


